Berkeley Lights BLI 深 沪
已收盘 03-21 16:00:00 美东时间
1.20
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.20
- 总市值 8660.87万
- 52周最高 7.79
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.14
- 委 比 0.00%
- 总股本 7217.39万
- 历史最高 113.53
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.14
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多The Glimpse Group Engages Lucid Capital Markets For Potential IPO Or Spinoff Of Brightline Interactive Unit
The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR), a diversified Immersive Technology platform company providing enterprise-focused Immersive Technology, Spatial Computing and Artificial Intelligence ("AI") driven
10-27 20:55
Two Famous Felines Join Forces: Blitzy Meets Garfield in Bingo Blitz
Classic cartoon charm meets social gameplay in Bingo Blitz's newest collaboration. HERZLIYA, Israel, Sept. 16, 2025 /PRNewswire/ -- Bingo Blitz, the #1 free-to-play bingo game*, is bringing ...
09-16 20:15
英伟达迎来一群劲敌
原标题：英伟达迎来一群劲敌 近期发布的超以太网（Ultra Ethernet，简称UE）1.0规范，为未来人工智能（AI）和高性能计算（HPC）系统定义了一套...
09-01 16:17
INTEGRA AND SHOSHONE-PAIUTE TRIBES ESTABLISH HISTORIC RELATIONSHIP AGREEMENT
TSXV: ITR; NYSE American: ITRG www.integraresources.com VANCOUVER, BC, Aug. 15, 2025 /PRNewswire/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is ...
08-15 18:00
突破！诺华Ianalumab III期成功：或成全球首个干燥综合征靶向药
前沿速递 8月11日，诺华制药宣布其研发的全人源单克隆抗体Ianalumab（VAY736）在干燥综合征两项关键III期临床试验（NEPTUNUS-1和NEP...
08-13 17:42
聚焦中法绿色合作：凯撒旅游欧洲公司见证四川能源发展集团欧洲盛会
2025年7月8日（星期二）上午，盛夏的巴黎迎来一场聚焦全球能源未来的高端对话。 由四川能源发展集团有限责任公司主办的“中法能源产业合作交流会”在法国首都隆重举...
07-15 10:18
中国药企全球领先“超级抗生素”申报上市
转自：上观新闻 近日，国家药监局传来好消息，国产创新药企信诺维研发的新型“超级抗生素”——注射用亚胺西福上市申请受获理了！它瞄准的是医院里非...
07-14 17:21
AbCellera Announces The Federal Circuit Upholds Validity Of Its '408 Patent On Microfluidic Cell-Culturing Devices, Rejecting Bruker Cellular's Invalidity Challenge And Strengthening AbCellera's Position In Ongoing Patent Litigation.
The Federal Circuit rejects Bruker Cellular's invalidity challenge to AbCellera's patent for microfluidic devices and their use in culturing cellsAbCellera (NASDAQ:ABCL) today announced that the United States Court of
05-13 03:33
Bruker Enters Functional Single-Cell Biology Research Solutions With PhenomeX Acquisition
Bruker Corporation (NASDAQ: BRKR) has agreed to acquire PhenomeX Inc (NASDAQ: CELL) for $1.00 per share in an
2023-08-18 00:41
AbCellera Announces That The U.S. Patent Trial And Appeal Board Has Denied Berkeley Lights' Request For Rehearing
PTAB rejects request by Berkeley Lights to reconsider its decision denying Berkeley's argument that AbCellera's U.S. patent is invalid AbCellera (NASDAQ:ABCL) announced that the United States Patent and
2023-07-25 04:18
